Biopeople
It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it. The article may be deleted if this message remains in place for seven days, i.e., after 08:47, 10 December 2024 (UTC). Find sources: "Biopeople" – news · newspapers · books · scholar · JSTOR |
 | This article contains promotional content. (July 2022) |
 | This article needs additional citations for verification. (June 2022) |
| Founded at | University of Copenhagen |
|---|---|
| Type | Publicly fund |
| Purpose | Global health and welfare |
Biopeople – Denmark's Life Science Cluster is a publicly funded partnership and National Center established, authorized and funded by the Ministry for Science and Higher Education. It is located at the Faculty of Health and Medical Sciences, University of Copenhagen. Biopeople helps academia and industry create and develop ideas together into new projects, products and services for the benefit of global health and welfare, stimulating innovation by bringing researchers and stakeholders together across disciplines, sectors and public-private boundaries.
Biopeople was the first European cluster organisation within health and life sciences to receive the recognition of Gold Label of the European Cluster Excellence Initiative (ECEI).[1]
Structure
[edit]Member companies and affiliates include Novo Nordisk, Lundbeck, LEO Pharma, Danisco, Novozymes, Chr. Hansen, and many small and medium enterprises.
See also
[edit]- Clinical trial
- Contract Research Organization
- Drug development
- Drug design
- Drug discovery
- Functional beverage
- Health claims on food labels
- Medical food, specially formulated foods to treat diseases with distinctive nutritional needs (e.g., an inability to metabolize a common molecule)
- Nutraceuticals
- Nutrigenomics
- Preventive medicine
References
[edit]- ^ Parkel, Sven (2013-01-01). "Biopeople receives European praise". Scanbalt. Retrieved 2023-11-06.